Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin.
World journal of gastroenterology(2023)
摘要
Serum PIVKA-II has better performance in detecting HCC at an early stage for CLD patients with normal serum TBIL.
更多查看译文
关键词
Chronic liver disease,Diagnosis,Hepatitis B virus,Hepatocellular carcinoma,Protein induced by vitamin K absence or antagonist-II,Total bilirubin
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要